US 10123974
Sustained release formulation of a non-steroidal anti-inflammatory drug
granted A61KA61K31/196A61K31/407
Quick answer
US patent 10123974 (Sustained release formulation of a non-steroidal anti-inflammatory drug) held by Pacira Pharmaceuticals, Inc. expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pacira Pharmaceuticals, Inc.
- Grant date
- Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/196, A61K31/407, A61K31/5415, A61K9/127